Statins showed no clear difference in combined outcome of non‐fatal myocardial infarction, non‐fatal… compared with control at 4 months (3 to 6 months) (moderate certainty).
Statins showed no clear difference in death from all causes compared with control at 4 months (3 to 6 months) (moderate certainty).
Statins showed no clear difference in fatal and non‐fatal myocardial infarction or reinfarction compared with control at 4 months (3 to 6 months) (moderate certainty).
Statins showed no clear difference in fatal and non‐fatal stroke compared with control at 4 months (3 to 6 months) (moderate certainty).
Statins probably leads to lower unstable angina compared with control at 4 months (3 to 6 months) (moderate certainty).
Statins showed no clear difference in acute heart failure compared with control at 4 months (3 to 6 months) (moderate certainty).
Statins showed no clear difference in rhabdomyolysis compared with control at 4 months (3 to 6 months) (low certainty).
Statin showed no clear difference in mean pressure gradient (mmHg) Better indicated by lower scores. compared with placebo (low certainty).
Statin showed no clear difference in valve area (cm2) Better indicated by higher scores. compared with placebo (low certainty).
Statin showed no clear difference in aortic jet velocity (m/s) compared with placebo (low certainty).
Statin showed no clear difference in freedom from valve replacement compared with placebo (moderate certainty).
Statin showed no clear difference in death from cardiovascular cause compared with placebo (low certainty).
It is very uncertain whether statin changes hospitalisation for any reason compared with placebo (very low certainty).
Statin showed no clear difference in adverse events ‐ Muscle pain compared with placebo (moderate certainty).